Logo image of DRUG

BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Income Statement

NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD

37.65  +0.4 (+1.07%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2020-9-30)
Revenue
DRUG Revenue ChartDRUG Revenue over time chart
0.000.000.000.000.00
Operating Expenses
DRUG Operating Expenses ChartDRUG Operating Expenses over time chart
3.60M7.37M14.97M8.80M480.38K
Research and Development
DRUG Research and Development ChartDRUG Research and Development over time chart
3.12M5.00M12.18M6.31M193.55K
Selling, General, and Administrative Expenses
DRUG Selling, General, and Administrative Expenses ChartDRUG Selling, General, and Administrative Expenses over time chart
1.69M2.29M2.79M2.47M281.26K
Operating Income
DRUG Operating Income ChartDRUG Operating Income over time chart
-3.60M-7.37M-14.97M-8.80M-480.38K
Interest Income/Expense
DRUG Interest Income/Expense ChartDRUG Interest Income/Expense over time chart
41.61K-5.56K9.98K154.10KN/A
Non Recurring Items
DRUG Non Recurring Items ChartDRUG Non Recurring Items over time chart
N/A0.00-2.00KN/AN/A
Income Before Taxes
DRUG Income Before Taxes ChartDRUG Income Before Taxes over time chart
-3.56M-7.37M-14.96M-8.65M-480.38K
Net Income
DRUG Net Income ChartDRUG Net Income over time chart
-3.56M-7.37M-14.96M-8.65M-480.38K
EBITDA
DRUG EBITDA ChartDRUG EBITDA over time chart
-3.53M-7.29M-14.97MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
DRUG EPS Diluted Total Ops ChartDRUG EPS Diluted Total Ops over time chart
-0.92-1.98-6.06-4.82-0.38
 
Statistics

All data in CAD

Charts

DRUG Income Statement data chartDRUG Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2019 2020 2021 2022 2023 TTM -5M -10M
DRUG Earnings Per Share (EPS) chartDRUG EPS Diluted and non-GAAP ChartEarnings Per Share 2019 2020 2021 2022 2023 TTM -2 -4 -6